Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Vogel

Showing results (1-10 of 363) with videos related to

Pageof 37
Sort By:
Future Oncology (London, England)|October 13, 2020
Targeting FGFR2 in advanced cholangiocarcinoma: an interview with Arndt VogelArndt Vogel
Cancer Treatment Reviews|January 4, 2020
Corrigendum to "Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma" [Cancer Treatm. Rev. 82 (2019) 101946]Arndt Vogel, Anna Saborowski
Journal of Hepatology|April 30, 2026
Global biliary tract cancer genomics: from geographic patterns toward biological subtypesAnna Saborowski, Arndt Vogel
JHEP Reports : Innovation in Hepatology|April 23, 2026
Perioperative immunotherapy to reduce recurrence in resectable hepatocellular carcinoma - lessons learned from the CARES-009 trialLaia Aceituno, Arndt Vogel
Journal of Hepatology|September 20, 2021
Medical therapy of HCCArndt Vogel, Anna Saborowski
The Lancet. Gastroenterology & Hepatology|March 14, 2020
Adjuvant <sup>131</sup>I-metuximab in hepatocellular carcinoma: a new option for an old drug?Arndt Vogel, Anna Saborowski
Cancer Treatment Reviews|December 13, 2019
Current strategies for the treatment of intermediate and advanced hepatocellular carcinomaArndt Vogel, Anna Saborowski
Digestion|March 14, 2017
Cholangiocellular CarcinomaArndt Vogel, Anna Saborowski
Liver International : Official Journal of the International Association for the Study of the Liver|January 2, 2023
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?Arndt Vogel, Ana Lleo
Viszeralmedizin|August 20, 2015
Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?Arndt Vogel, Oliver Dudeck
Pageof 37

Showing results (1-10 of 363) with videos related to

Sort By:
Pageof 37
Future Oncology (London, England)|October 13, 2020
Targeting FGFR2 in advanced cholangiocarcinoma: an interview with Arndt VogelArndt Vogel
Cancer Treatment Reviews|January 4, 2020
Corrigendum to "Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma" [Cancer Treatm. Rev. 82 (2019) 101946]Arndt Vogel, Anna Saborowski
Journal of Hepatology|April 30, 2026
Global biliary tract cancer genomics: from geographic patterns toward biological subtypesAnna Saborowski, Arndt Vogel
JHEP Reports : Innovation in Hepatology|April 23, 2026
Perioperative immunotherapy to reduce recurrence in resectable hepatocellular carcinoma - lessons learned from the CARES-009 trialLaia Aceituno, Arndt Vogel
Journal of Hepatology|September 20, 2021
Medical therapy of HCCArndt Vogel, Anna Saborowski
The Lancet. Gastroenterology & Hepatology|March 14, 2020
Adjuvant <sup>131</sup>I-metuximab in hepatocellular carcinoma: a new option for an old drug?Arndt Vogel, Anna Saborowski
Cancer Treatment Reviews|December 13, 2019
Current strategies for the treatment of intermediate and advanced hepatocellular carcinomaArndt Vogel, Anna Saborowski
Digestion|March 14, 2017
Cholangiocellular CarcinomaArndt Vogel, Anna Saborowski
Liver International : Official Journal of the International Association for the Study of the Liver|January 2, 2023
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?Arndt Vogel, Ana Lleo
Viszeralmedizin|August 20, 2015
Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?Arndt Vogel, Oliver Dudeck
Pageof 37